Israel Englander Monte Rosa Therapeutics, Inc. Transaction History
Millennium Management LLC
- $207 Billion
- Q2 2024
A detailed history of Israel Englander (Millennium Management LLC) transactions in Monte Rosa Therapeutics, Inc. stock. As of the latest transaction made, Millennium Management LLC holds 20,928 shares of GLUE stock, worth $197,769. This represents 0.0% of its overall portfolio holdings.
Number of Shares
20,928
Previous 150,025
86.05%
Holding current value
$197,769
Previous $1.06 Million
92.62%
% of portfolio
0.0%
Previous 0.0%
Shares
6 transactions
Others Institutions Holding GLUE
# of Institutions
76Shares Held
40.5MCall Options Held
84.2KPut Options Held
20.6K-
Nea Management Company, LLC Timonium, MD7.69MShares$72.7 Million2.72% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD5.98MShares$56.5 Million0.0% of portfolio
-
Baker Bros. Advisors LP New York, NY4.92MShares$46.5 Million0.24% of portfolio
-
Avoro Capital Advisors LLC New York, NY4.54MShares$42.9 Million0.23% of portfolio
-
Suvretta Capital Management, LLC New York, NY2.66MShares$25.1 Million0.42% of portfolio
About Monte Rosa Therapeutics, Inc.
- Ticker GLUE
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 46,713,900
- Market Cap $441M
- Description
- Monte Rosa Therapeutics, Inc., a biopharmaceutical company, engages in the development of novel small molecule precision medicines that employ the body's natural mechanisms to selectively degrade therapeutically relevant proteins. It develops an oral molecular glue degrader for GSPT1, a translational termination factor and degron-containing prot...